Reactivation of hepatitis B but not hepatitis c in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients

Hepato-Gastroenterology

Volumn 46, Issue 29, 1999, Pages 2925-2930

  Markovic, Sasa ^a   Drozina, Gorazd ^a   Vovk, Marjeta ^a   Fidler Jenko, Marija ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Corticosteroids; Fulminant hepatic failure; Hepatitis B reactivation; Hepatitis C; Malignant lymphoma; Prevalence

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; GLUCOCORTICOID; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FATALITY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; SLOVENIA; VIRUS REACTIVATION;

ADRENAL CORTEX HORMONES; ADULT; AGED; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HODGKIN DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; RISK FACTORS; SLOVENIA; SURVIVAL RATE; VIRUS ACTIVATION;

EID: 0032719594     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. 1 Gupta S, Govindarajan S, Fong TL, Redeker AG: Spontaneous reactivation in chronic hepatitis B: patterns and natural History. J Clin Gastroenterol 1990; 12:562-568.
2. 2 Gitnick G: Hepatitis infections in immunocompromised patients. Gastroenterol Clin N A 1994; 23:515-521.
3. 3 Wands JR, Chura CM, Roll FJ, Maddrey WC: Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterol 1975; 68:105-112.
4. 4 Hoofnagel JH, Dusheiko GM, Schafer DF, Jones EA, Micetich KJ, Young RC, Casto J: Reactivation of chronic B virus infection by cancer chemotherapy. Ann Intern Med 1982; 96:447-449.
5. 5 Lau JYN, Lai CL, Lin HJ, Lok AS, Liang RH, Wu PC, Chan TK, Todd D: Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q J Med 1989; 73:911-917.
6. 6 Liang RHS, Lok AS, Lai CL, Chan Tk, Todd D, Chin EK: Hepatitis B infection in patients with lymphoma. Hematol Oncol 1990; 8:261-270.
7. 7 Pinto PC, Hu E, Bernstein-Singer M, Pinter-Brown L, Govindarajan S: Acute hepatic injury after withdrawal of immunosuppressive chemotherapy in patients with hepatitis B. Cancer 1990; 65:878-884.
8. 8 Lok SAF, Liang RHS, Chiu EKW, Wong KL, Chan TK, Todd D: Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100:182-188.
9. 9 Yoshiba M, Sekiyama K, Sugata F, et al: Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment. Dig Dis Sci 1992; 37:1253-1259.
10. 10 Nakamura Y, Motokura T, Fujita A, Yamashita T, Ogata E: Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Cancer 1996; 78:2210-2215.
11. 11 Onwubalil JK: Fulminant hepatic failure in nephrotic syndrome related to withdrawal of immunosuppressive therapy. Postgrad Med J 1988; 64:325-327.
12. 12 Kogay Y, Kumashiro R, Yasumoto K, Shakedo S, Ono N, Noguchi N, Nagata K, Sata M, et al: Two fatal cases of hepatitis B virus carriers after corticosteroid therapy for bronchial asthma. Intern Med 1992; 31:208-213.
13. 13 Webster A, Brenner MK, Prentice HG, Griffiths PD: Fatal hepatitis B reactivation after autologous bone marrow transplantation. Bone Marrow Transpl 1989; 4:207-208.
14. 14 Konig V, Hopf U, Neuhaus P, Bauditz J, Schmidt CA, Blumhardt G, Bechstein WO, Neuhaus R, Lobeck H: Long-term follow up of hepatitis B virus-infected recipients after orthotopic liver transplantation. Transplantation 1994; 58:553-559.
15. 15 Dusheiko G, Song E, Bowyers S, Whitcutt M, Maier G, Meyers A, Kew MC: Natural history of hepatitis B virus infection in renal transplant recipients - a fifteen-year follow-up. Hepatology 1983; 3:330-335.
16. 16 Rehermann B: Immunopathogenesis of viral hepatitis. Balliere's Clin Gastroenterol 1996; 10:483-500.
17. 17 Cooksley WGE, McIvor CA: Fibrosing cholestatic hepatitis and HBV after bone marrow transplantation. Biomed Pharmacother 1995; 49:117-124.
18. 18 Koziel MJ: The role of immune responses in the pathogenesis of hepatitís C virus infection. J Viral Hepatitis 1997; 4(Suppl 2):31-41.
19. 19 Gruber A, Lundberg LG, Bjorkholm M: Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy. J Intern Med 1993; 234:223-225.
20. 20 Kagawa T, Saito H, Tada S, Tsunematsu S, Morizane T, Tsuchiya M: Is hepatitis C virus cytopathic? Lancet 1993; 34:316-317.
21. 21 Vento S, Cainelli F, Mirandola F, Cosco L, Di Perri G, Solbiati M, Ferraro T, Concia E: Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996; 347:92-93.
22. 22 Pozzato G, Mazzaro C, Santini F, Burrone O: Hepatitis C virus and non-Hodgkin's lymphoma. Leuk Lymphoma 1996; 22:53-60.
23. 23 Ellenrieder V, Weidenrbach H, Frickhofen N, Michel D, Prummer O, Klatt S, Bernas O, Mertens T, Adler G, Beckh K: HCV and HGV and non-Hodgkin's lymphoma. J Hepatol 1998; 28:34-39.
24. 24 Lee WM: Hepatitis B virus Infection. New Engl J Med 1997; 337:1733-1745.
25. 25 Chen PM, Fan S, Liu CJ, Hsieh RK, Liu JH, Chuang MW, et al: Changing of hepatitis B virus markers in patients with bone marrow transplantation. Transplantation 1990; 49:708-173.
26. 26 Lam KC, Lai CL, Trepo C, Wu PC: Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med 1981; 304:380-386.
27. 27 Tur-Kaspa R, Burk RD, Shaul Y, Schafritz D: Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci USA 1986; 83:1627-1631.
28. 28 Foirnaron S, Pol S, Legendre C, Carnot F, Mamzer-Bruneel MF, Brechot C, Kreis H: The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation 1996; 62:297-299.
29. 29 Caselitz M, Link H, Hein R, Maschek H, Boker K, Poliwoda H, Manns MP: Hepatitis B associated liver failure following bone marrow transplantation. J Hepatol 1997; 27: 572-577.
30. 30 Mertens T, Kock J, Hampl W, Schlicht HJ, Tillmann HL, Oldhaffer KJ, Manns MP, Arnold R: Reactivated fulminant hepatitis B virus replication after bone marrow transplantation: clinical course and possible treatment with ganeiclovir. J Hepatol 1996; 25:968-971.
31. 31 Cheng AL: Steroid free chemotherapy decreases the risk of hepatitis flare ups in hepatitis B virus carriers with non-Hodgkin's lymphoma. Blood 1996; 87:1202.
32. 32 Mels GC, Bellati G, Leandro G, Brunetto MR, Vicari O, Piantino P, Borzio M, Angeli G, Ideo G, Bonino F: Role of IgM antibody to hepatitis B core antigen in the diagnosis of hepatitis B exacerbations. Arch Virol 1993; 8(Suppl):203-211.
33. 33 Naumov NV, Eddleston ALW: Host immune response and variations in the virus genome: pathogenesis of liver damage caused by hepatitis B virus. Gut 1994; 35:1013-1017.